Outcomes after bronchoscopic lung volume reduction (BLVR) for patients with advanced emphysema were not significantly affected by the level of heterogeneity before the procedure, based on data from ...

Plasma epigenomic profiling to reveal molecular correlates of response and resistance to 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer (mCRPC). Comparative effectiveness of ...

Nivolumab plus ipilimumab significantly improves OS and PFS in NSCLC compared to chemotherapy, with a 30% reduction in death risk and no significant heterogeneity observed. Amivantamab plus lazertinib ...

Key architectural considerations that enable scalable, low-latency, and power-efficient data movement.